Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 26 May 2026
- Expected to end
- May 2028
- Type of study
- Observational, 2 groups
- Treatments tested
- Superficial skin swabs
- Stool samples
- Saliva samples
- Blood samples
- Data-Collection
- Record updated
- 30 June 2026
Who can take part
- Age
- 10 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Group A:
- Children aged 10 years and older and adults with confirmed Netherton syndrome diagnosed at age 10 years or older (clinical and histological and/or molecular)
- Patients and legal guardians informed about the study and not opposed to participation in the study; Group B:
- Children aged 10 years and older and adults with no skin barrier impairment, dermatosis, inflammatory disease, or autoimmune disease
- Subjects and legal guardians informed about the study and who do not object to participation in the study
Who cannot take part
- General or local antibiotic therapy within the month preceding the consultation
- Refusal by parents/guardians, children, adolescents, or adults
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
It is proposed to conduct an exploratory study to analyze the skin, intestinal, and salivary microbiome, as well as the skin mycobiome and virome, of patients (adolescents and young adults) with Netherton syndrome, a condition characterized by an impaired skin barrier that most likely promotes the development of allergic manifestations.
Read full original descriptionShow less
The study will be conducted on patients with Netherton syndrome and control subjects in order to investigate possible correlation factors between the three microbiomes and identify which ones.
The 2 groups in the trial
- Patients with Netherton syndrome
15 children, adolescents, and young adults with Netherton syndrome
Treatment: Superficial skin swabs, Stool samples, Saliva samples, Blood samples, and Data-Collection
- Control subjects
15 control subjects of the same age group and gender, treated at the service but with no dermatosis or inflammatory and/or autoimmune diseases.
Treatment: Superficial skin swabs, Stool samples, Saliva samples, Blood samples, and Data-Collection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 30 June 2026